GALE Key Stats
- Here's What This $34 Billion Fund Has Been Buying Fool Dec 6
- 4 Reasons Why Galena Biopharma Is Headed Higher Wall St. Cheat Sheet Dec 4
- Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference noodls Dec 4
- Perilous Reversal Stock: Galena Biopharma (GALE) The Street Dec 3
- Why Galena, SouFun, and Marathon Petroleum Are Today's 3 Best Stocks Fool Dec 2
- Notable 52-Week Highs and Lows of the Day 12/02: (GALE) (BOSC) (FRX) High; (CIE) (FTNT) Low Street Insider Dec 2
- Galena: A Pipeline Rich For Investors Seeking Alpha Dec 2
- Biotech Stocks Partying Like It's 1999 The Street Dec 2
- 2 Team Alpha Portfolio Updates: Selling Several Losing Positions And Performance Reviews Seeking Alpha Dec 2
- Biotech Stocks With Promise The Street Nov 29
GALE Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Galena Biopharma is up 104.1% over the last year vs S&P 500 Total Return up 30.90%, Ariad Pharmaceuticals down 81.29%, and Celldex Therapeutics up 345.3%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Balance Sheet View Statement
Pro Ratings for GALE
Pro Strategies Featuring GALE
Did Galena Biopharma make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Galena Biopharma Inc is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics.